Andernach (ots) - LTS, a leading pharmaceutical technology company, announced today that it has received a grant from the Bill & Melinda Gates Foundation. The grant will support new formulation methods for mRNA, such as dissolvable microneedle array ...
To the press release of LTS Lohmann Therapie-Systeme AG